C62H70Cu3N4O32, monoclinic, C2/c (no. 15), a = 44.710(7) Å, b = 12.8847(17) Å, c = 11.9901(18) Å, β = 102.286(13)°, V = 6749.0(17) Å3, Z = 4, Rgt(F) = 0.0618, wRref(F2) = 0.1978, T = 293(2) K
In the title compound, [Cu2(C7HF4O2)4(C12H8N2)2]·2H2O, the CuII ion has a square-pyramidal coordinat...
C60H40N4O9Cu, triclinic, P1̄ (no. 2), a = 9.6569(8) Å, b = 10.3941(7) Å, c = 24.9421(16) Å, α = 97.1...
C80H96N32Cu11Br14, triclinic, P1̄ (no. 2), a = 11.370(2) Å, b = 14.287(3) Å, c = 17.621(3) Å, α = 85...
C28H26CuN2O9, monoclinic, C2/c, a = 12.3146(11) Å, b = 11.1769(10) Å, c = 19.3856(17) Å, β = 101.012...
C50H64Cu4N8O26, triclinic, P1̄ (no. 2), a = 11.0000(3) Å, b = 11.2890(3) Å, c = 12.4370(4) Å, α = 10...
C47H45Cl2N9Cu3O6, monoclinic, C2/c (no. 15), a = 24.084(9) Å, b = 12.152(5) Å, c = 17.404(7) Å, β = ...
C46H32Cu2N8O12, monoclinic, P21/c, a = 9.5638(9)Å, b = 20.2142(19) Å, c = 12.0825(11) Å, β = 94.69...
C54H42Cd3O24, triclinic, P1̄ (no. 2), a = 7.9122(5) Å, b = 9.0693(6) Å, c = 18.6637(11) Å, β = 100.7...
C49H40BCu2F4Fe2N5O5, triclinic, P1̄ (no. 2), a = 11.526(2) Å, b = 12.902(2) Å, c = 15.469(3) Å, α = ...
C36H36Cu4N16O4, triclinic, P1̄ (no. 2), a = 9.6157(7) Å, b = 10.5256(7) Å, c = 10.7201(7) Å, α = 82....
C52H36C14N4O14Pb2·2(H2O), triclinic, P1‾$P‾{1}$ (no. 2), a = 9.1186(4) Å, b = 12.8031(6) Å, c...
C40H28N4O10Cd, monoclinic, P21/c (no. 14), a = 9.5953(8) Å, b = 22.1448(17) Å, c = 16.3937(13) Å, β ...
C7H4CuF6NO4, triclinic, P1̄ (no. 2), a = 8.5122(5) Å, b = 8.5458(6) Å, c = 8.8674(6) Å, α = 75.042(3...
C28H32Cl2Cu4N4O11, triclinic, P1̅ (no. 2), a = 9.115(3) Å, b = 12.769(4) Å, c = 14.870(5) Å, α = 93....
The compound having an empirical formula Cu8C24H64O56, corresponding to copper(II) malonate trihydra...
In the title compound, [Cu2(C7HF4O2)4(C12H8N2)2]·2H2O, the CuII ion has a square-pyramidal coordinat...
C60H40N4O9Cu, triclinic, P1̄ (no. 2), a = 9.6569(8) Å, b = 10.3941(7) Å, c = 24.9421(16) Å, α = 97.1...
C80H96N32Cu11Br14, triclinic, P1̄ (no. 2), a = 11.370(2) Å, b = 14.287(3) Å, c = 17.621(3) Å, α = 85...
C28H26CuN2O9, monoclinic, C2/c, a = 12.3146(11) Å, b = 11.1769(10) Å, c = 19.3856(17) Å, β = 101.012...
C50H64Cu4N8O26, triclinic, P1̄ (no. 2), a = 11.0000(3) Å, b = 11.2890(3) Å, c = 12.4370(4) Å, α = 10...
C47H45Cl2N9Cu3O6, monoclinic, C2/c (no. 15), a = 24.084(9) Å, b = 12.152(5) Å, c = 17.404(7) Å, β = ...
C46H32Cu2N8O12, monoclinic, P21/c, a = 9.5638(9)Å, b = 20.2142(19) Å, c = 12.0825(11) Å, β = 94.69...
C54H42Cd3O24, triclinic, P1̄ (no. 2), a = 7.9122(5) Å, b = 9.0693(6) Å, c = 18.6637(11) Å, β = 100.7...
C49H40BCu2F4Fe2N5O5, triclinic, P1̄ (no. 2), a = 11.526(2) Å, b = 12.902(2) Å, c = 15.469(3) Å, α = ...
C36H36Cu4N16O4, triclinic, P1̄ (no. 2), a = 9.6157(7) Å, b = 10.5256(7) Å, c = 10.7201(7) Å, α = 82....
C52H36C14N4O14Pb2·2(H2O), triclinic, P1‾$P‾{1}$ (no. 2), a = 9.1186(4) Å, b = 12.8031(6) Å, c...
C40H28N4O10Cd, monoclinic, P21/c (no. 14), a = 9.5953(8) Å, b = 22.1448(17) Å, c = 16.3937(13) Å, β ...
C7H4CuF6NO4, triclinic, P1̄ (no. 2), a = 8.5122(5) Å, b = 8.5458(6) Å, c = 8.8674(6) Å, α = 75.042(3...
C28H32Cl2Cu4N4O11, triclinic, P1̅ (no. 2), a = 9.115(3) Å, b = 12.769(4) Å, c = 14.870(5) Å, α = 93....
The compound having an empirical formula Cu8C24H64O56, corresponding to copper(II) malonate trihydra...
In the title compound, [Cu2(C7HF4O2)4(C12H8N2)2]·2H2O, the CuII ion has a square-pyramidal coordinat...
C60H40N4O9Cu, triclinic, P1̄ (no. 2), a = 9.6569(8) Å, b = 10.3941(7) Å, c = 24.9421(16) Å, α = 97.1...
C80H96N32Cu11Br14, triclinic, P1̄ (no. 2), a = 11.370(2) Å, b = 14.287(3) Å, c = 17.621(3) Å, α = 85...